Inactive Instrument

Immunosyn Corp Share Price

Stocks

End-of-day quote Other OTC Other stock markets
- ^USD	-

30/-1/30	IMMUNOSYN CORP COM STK USD0.0001 : Immunosyn Announces Proposed Agreements for Distribution of the Biopharmaceutical SF-1019 in Utah	PR
30/-1/30	Immunosyn Corp Com Stk Usd0.0001 : Immunosyn Corporation Files 10-Q	PR
30/-1/30	Immunosyn Corp Com Stk Usd0.0001 : Immunosyn Corporation Announces 2007 Results, Files 10KSB	PR
30/-1/30	Immunosyn Corp Com Stk Usd0.0001 : Immunosyn Releases Wound Healing Photographs From the First Phase 'Proof of Concept Trial' in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019	PR
30/-1/30	Immunosyn Corp Com Stk Usd0.0001 : Douglas A. McClain, Jr. Resumes CFO Duties at Immunosyn	PR

Manager	Title	Age	Since
Stephen D. Ferrone CEO	Chief Executive Officer	75	15/10/2007
Douglas A. McClain DFI	Director of Finance/CFO	51	-

Director	Title	Age	Since
Stephen D. Ferrone BRD	Director/Board Member	75	09/07/2011
Douglas A. McClain CHM	Chairman	51	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
REGENERON PHARMACEUTICALS, INC.	-0.22%	+2.04%	+16.21%	-8.03%	6.76TCr
UCB	-0.63%	-9.21%	+37.82%	+200.20%	5.16TCr
SAMSUNG BIOLOGICS CO.,LTD.	+0.36%	+40.00%	+40.00%	+40.00%	4.3TCr
CSL LIMITED	-1.26%	-0.39%	-49.63%	-53.84%	4.09TCr
BIOGEN INC.	+4.96%	+0.27%	+57.04%	-24.80%	2.94TCr
MODERNA, INC.	-1.85%	-18.08%	+103.86%	-47.07%	2.71TCr
INCYTE CORPORATION	-2.12%	-1.20%	+63.23%	+84.42%	2.33TCr
INNOVENT BIOLOGICS, INC.	-0.67%	+1.48%	+10.61%	+188.35%	1.99TCr
SWEDISH ORPHAN BIOVITRUM AB	-2.12%	-3.92%	+56.13%	+130.60%	1.69TCr
Average	-0.40%	-3.29%	+37.25%	+56.65%	3.55TCr
Weighted average by Cap.	-0.27%	-3.06%	+30.84%	+47.62%

Employees

Sector